Sublingual Semaglutide (generic Ozempic®) now available! Get Started
Dashboard
Compound Catalog

Aminolevulinic Acid Hydrochloride

Aminolevulinic Acid Hydrochloride is a versatile active pharmaceutical ingredient commonly utilized in dermatological and oncological treatments. It serves as a precursor in the biosynthesis of heme, playing a crucial role in photodynamic therapy (PDT) for various skin conditions, including actinic keratosis and certain types of superficial skin cancers.

By promoting the accumulation of protoporphyrin IX, Aminolevulinic Acid Hydrochloride enhances the photosensitivity of targeted cells, allowing for effective treatment upon exposure to specific wavelengths of light. This targeted approach minimizes damage to surrounding healthy tissues, making it a preferred choice for clinicians seeking precision in therapeutic interventions.

Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
This is some text inside of a div block.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active Ingredient Information

A small arrow pointing down

Aminolevulinic Acid Hydrochloride is a pivotal active pharmaceutical ingredient utilized in various compounded formulations, primarily for its role in photodynamic therapy. This compound is a prodrug that, upon topical application, is metabolized into protoporphyrin IX, a photosensitizer that accumulates in abnormal cells. When exposed to specific wavelengths of light, it generates reactive oxygen species, leading to targeted cytotoxic effects on dysplastic or neoplastic cells.

Clinically, Aminolevulinic Acid Hydrochloride is employed in the treatment of actinic keratosis, superficial basal cell carcinoma, and other dermatological conditions where selective phototoxicity is beneficial. Its mechanism of action allows for precision in targeting abnormal cells while sparing surrounding healthy tissue, making it a valuable tool in dermatological oncology. The efficacy of this API is enhanced by its ability to penetrate the stratum corneum and localize within the epidermis, ensuring optimal therapeutic outcomes.

Prescribers should be aware of the photosensitivity associated with Aminolevulinic Acid Hydrochloride, necessitating patient education on light exposure post-application. The compound's pharmacokinetics and safety profile are well-documented, with a favorable balance between therapeutic benefits and manageable side effects. As a versatile component in compounded formulations, it offers customizable treatment options tailored to individual patient needs, enhancing the scope of personalized medicine in dermatology.

Formulas using

Aminolevulinic Acid Hydrochloride

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.